Woodline Partners’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
261,120
+50,654
+24% +$3.68M 0.08% 318
2025
Q4
$15.9M Buy
210,466
+153,145
+267% +$9.65M 0.06% 357
2025
Q3
$2.28M Sell
57,321
-812,887
-93% -$31M 0.01% 711
2025
Q2
$37.8M Sell
870,208
-190,845
-18% -$7.26M 0.2% 144
2025
Q1
$39.6M Buy
1,061,053
+45,445
+4% +$1.76M 0.26% 118
2024
Q4
$46M Buy
1,015,608
+39,453
+4% +$2.01M 0.31% 90
2024
Q3
$57.3M Buy
976,155
+229,996
+31% +$11M 0.48% 51
2024
Q2
$29.4M Buy
746,159
+43,738
+6% +$2.12M 0.28% 113
2024
Q1
$46.7M Buy
702,421
+376,319
+115% +$16.4M 0.43% 62
2023
Q4
$9.11M Buy
326,102
+16,102
+5% +$323K 0.1% 239
2023
Q3
$6.6M Buy
+310,000
New +$6.83M 0.08% 275

Other funds holding APGE